GlassScriptPhysician profile
Robin Michelle Cohen
NPI 1073788535
$9,105.73
in general payments reported to CMS, 2019-2025
63 companies · $918 in 2025
The $918 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,678 · 2022: $2,497 · 2023: $2,060 · 2024: $952 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,542 · Education: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,542.49 |
| Education | $387.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,670.72 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $519.65 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $513.56 | 2021-2025 | Imfinzi, Enhertu |
| Incyte Corporation | $500.49 | 2021-2024 | Monjuvi, Jakafi, Pemazyre |
| Pfizer INC. | $453.74 | 2021-2024 | |
| Daiichi Sankyo INC. | $439.33 | 2021-2025 | Enhertu |
| Janssen Biotech, INC. | $435.33 | 2021-2025 | Tecvayli, Darzalex, Akeega |
| Lilly USA, LLC | $305.88 | 2021-2024 | Jaypirca, Verzenio |
| Pharmacyclics LLC, An Abbvie Company | $289.64 | 2022-2023 | Imbruvica |
| Astellas Pharma US INC | $245.97 | 2021-2023 | |
| Genzyme Corporation | $245.16 | 2021-2025 | |
| Puma Biotechnology, INC. | $222.48 | 2021-2024 | Nerlynx |
| Dova Pharmaceuticals | $199.91 | 2021 | |
| Amgen INC. | $191.55 | 2021-2023 | Xgeva, Vectibix, Nplate |
| E.R. Squibb & Sons, L.L.C. | $157.29 | 2021-2022 |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.